In summary, our cellular and genetic evidence supported a directly promoting effect of IRX3 on the browning program of white adipocytes by regulating UCP1 transcription and provided a new view for the association of rare variants in IRX3, as one candidate target of FTO variants, with human obesity risk. Here, IRX3 is linked to obesity disorder.